ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
January 2026
Fusion Science and Technology
November 2025
Latest News
Jeff Place on INPO’s strategy for industry growth
As executive vice president for industry strategy at the Institute of Nuclear Power Operations, Jeff Place leads INPO’s industry-facing work, engaging directly with chief nuclear officers.
Michel Alais, Rene Berger, Rene Boucher, Kenneth A. Gasper, Paul Laurens
Nuclear Technology | Volume 26 | Number 3 | July 1975 | Pages 307-319
Technical Paper | Radioisotope | doi.org/10.13182/NT75-A24432
Articles are hosted by Taylor and Francis Online.
The isotopic cardiac pacemaker directly applies nuclear technology to the field of medicine. Developed in 1970, the Laurens-Alcatel Model 9000 Pacemaker is now being implanted in humans in strict accordance with procedures set down by various regulatory agencies. This paper is an interim report on the reliability tests (with the resultant data) that have been performed on the isotopic cardiac pacemaker. The theoretical data for the longevity of the isotopic generator are discussed, as are the results for resistance to shock and corrosion tests. Comparative data are also given on the energy density of the isotopic generator and compared with other electrical power sources commonly used in cardiac pacing. The source thermal 238Pu source has also been subjected to increasingly severe tests to ensure complete containment of all radioactive material.